Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
| Status: | Archived |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2011 |
| End Date: | November 2011 |
This is a Phase 1, randomized, double-blind, active- and placebo-controlled, multicenter,
dose-ranging study to evaluate the safety, tolerability and Immunogenicity of a single
non-adjuvanted dose of the H1 VLP Influenza vaccine in healthy adults 18-49 years of age.
We found this trial at
1
site
Click here to add this to my saved trials
